- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.11.25 | Gilead reports Trodelvy breast cancer trial missed primary survival endpoint | ||
| 18.11.25 | Novo Nordisk reports phase 3 data showing semaglutide reduces liver scarring | ||
| 18.11.25 | InflaRx reports positive phase 2 results for HS and CSU treatments | ||
| 17.11.25 | Amgen reports positive results from landmark cardiovascular study | ||
| 17.11.25 | AstraZeneca reports positive results from rare disease trial | ||
| 14.11.25 | Scientists uncover new drug target in fight against antimicrobial resistance | ||
| 14.11.25 | Merck ends development agreement with Dr Falk Pharma for monoclonal antibody | ||
| 13.11.25 | Lilly and MeiraGTx partner in $475m ophthalmology deal | ||
| 13.11.25 | Smurfit Westrock unveils new clinical packaging facility at Dublin Airport | ||
| 12.11.25 | Johnson & Jonson secures FDA approval for multiple myeloma treatment | ||
| 12.11.25 | AstraZeneca reports positive results from phase 3 blood pressure trial | ||
| 12.11.25 | GenAI tools - creating a new era of scientific research | ||
| 11.11.25 | Genentech announces positive clinical results for BTK inhibitor MS treatment | ||
| 11.11.25 | Merck and Blackstone agree on funding for cancer protein antibody | ||
| 11.11.25 | The hidden strength of teams: how collaboration can build resilience | ||
| 10.11.25 | LEO Pharma receives NICE approval for chronic hand eczema cream | ||
| 10.11.25 | Pfizer and Metsera agree on merger after bidding war between Pfizer and Novo Nordisk | ||
| 10.11.25 | From disruption to resilience: India's growing role in pharma logistics | ||
| 07.11.25 | Novo Nordisk agrees to lower certain drug prices in the US | ||
| 07.11.25 | Lilly announces agreement with US government to lower patient costs | ||
| 07.11.25 | Support your backbone with legacy brands that deliver competitive edge | ||
| 06.11.25 | Boehringer Ingelheim and CDR-Life agree on deal worth up to $570m | ||
| 06.11.25 | Electra Therapeutics secures regulatory designations and funding for lead sHLH candidate | ||
| 06.11.25 | A new advent of clinical pathway management | ||
| 05.11.25 | Sandoz to acquire Just-Evotec Biologics to strengthen biosimilar development and manufacturing capabilities |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .